(Q35598464)

9 August 2017

title

Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised children and healthy adults (English)

1 reference

9 August 2017

1 reference

1 reference

5

Eneida Nemecek

1 reference

9 August 2017

Timothy A Driscoll

1

1 reference

9 August 2017

Lolie C Yu

2

1 reference

9 August 2017

Haydar Frangoul

3

1 reference

9 August 2017

Robert A Krance

4

1 reference

9 August 2017

Jeffrey Blumer

6

1 reference

9 August 2017

Antonio Arrieta

7

1 reference

9 August 2017

Michael L Graham

8

1 reference

9 August 2017

Scott M Bradfield

9

1 reference

9 August 2017

Alice Baruch

10

1 reference

9 August 2017

Ping Liu

11

1 reference

9 August 2017

language of work or name

English

0 references

publication date

3 October 2011

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

9 August 2017

volume

55

1 reference

9 August 2017

issue

12

1 reference

9 August 2017

page(s)

5770-5779

1 reference

Voriconazole pharmacokinetics and safety in immunocompromised children compared to adult patients

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232783

Voriconazole pharmacokinetics and pharmacodynamics in children

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232783

Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232783

Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232783

Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232783

Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232783

Effect of omeprazole on the steady‐state pharmacokinetics of voriconazole

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232783

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232783

In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232783

In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232783

Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232783

Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232783

Voriconazole therapeutic drug monitoring.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232783

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232783

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3232783

In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21968355

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00531-11

1 reference

9 August 2017

1 reference

9 August 2017

1 reference